These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9266432)

  • 1. Chronic administration of a partial agonist at strychnine-insensitive glycine receptors: a novel experimental approach to the treatment of ischemias.
    Fossom LH; Skolnick P
    J Neural Transm Suppl; 1997; 49():235-44. PubMed ID: 9266432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel treatment of global cerebral ischaemia with a glycine partial agonist.
    Von Lubitz DK; Lin RC; McKenzie RJ; Devlin TM; McCabe RT; Skolnick P
    Eur J Pharmacol; 1992 Aug; 219(1):153-8. PubMed ID: 1327834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wójcik E
    Pharmacol Biochem Behav; 1996 May; 54(1):73-7. PubMed ID: 8728541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): a partial agonist at strychnine-insensitive glycine sites.
    Fossom LH; Von Lubitz DK; Lin RC; Skolnick P
    Neurol Res; 1995 Aug; 17(4):265-9. PubMed ID: 7477740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitotoxic cell death dependent on inhibitory receptor activation.
    Chen Q; Moulder K; Tenkova T; Hardy K; Olney JW; Romano C
    Exp Neurol; 1999 Nov; 160(1):215-25. PubMed ID: 10630206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine-induced neurotoxicity in organotypic hippocampal slice cultures.
    Barth A; Nguyen LB; Barth L; Newell DW
    Exp Brain Res; 2005 Mar; 161(3):351-7. PubMed ID: 15490133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors.
    Trullas R; Jackson B; Skolnick P
    Pharmacol Biochem Behav; 1989 Oct; 34(2):313-6. PubMed ID: 2576136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
    Fossom LH; Basile AS; Skolnick P
    Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
    Boje KM; Wong G; Skolnick P
    Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease.
    Calabresi P; Centonze D; Pisani A; Bernardi G
    Exp Neurol; 1999 Jul; 158(1):97-108. PubMed ID: 10448421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection via strychnine-sensitive glycine receptors during post-ischemic recovery of excitatory synaptic transmission in the hippocampus.
    Tanabe M; Nitta A; Ono H
    J Pharmacol Sci; 2010; 113(4):378-86. PubMed ID: 20668364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wojcik E
    Neuropharmacology; 1997 Jan; 36(1):31-7. PubMed ID: 9144639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strychnine-insensitive glycine receptors in embryonic chick retina: characteristics and modulation of NMDA neurotoxicity.
    Boje KM; Skolnick P; Raber J; Fletcher RT; Chader G
    Neurochem Int; 1992 Jun; 20(4):473-86. PubMed ID: 1339019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic administration of a glycine partial agonist alters the expression of N-methyl-D-aspartate receptor subunit mRNAs.
    Bovetto S; Boyer P; Skolnick P; Fossom LH
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1503-8. PubMed ID: 9400027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.
    Witkin JM; Brave S; French D; Geter-Douglass B
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1267-73. PubMed ID: 8531091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity.
    Layer RT; Bland LR; Skolnick P
    Brain Res; 1993 Oct; 625(1):38-44. PubMed ID: 8242398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
    Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
    Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus.
    Peterson SL; Purvis RS; Griffith JW
    Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.